<DOC>
	<DOCNO>NCT02315066</DOCNO>
	<brief_summary>To assess safety tolerability increase dose level PF-04518600 alone combination wtih PF-05082566 patient select advanced metastatic carcinoma order determine maximum tolerate dose select recommend Phase 2 dose .</brief_summary>
	<brief_title>Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566</brief_title>
	<detailed_description />
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>Diagnosis hepatocellular carcinoma ( HCC ) ( Parts A1 A2 ) , melanoma ( Parts A1 B1 ) , clear cell renal cell carcinoma ( RCC ) ( Part A1 ) , head neck squamous cell carcinoma ( HNSCC ) ( Parts B1 B2 ) , non small cell lung cancer ( NSCLC ) ( Parts B1 B2 ) , urothelial bladder carcinoma ( Part B1 ) , gastric squamous cell carcinoma uterine cervix ( Part B1 ) progress intolerant standard therapy , standard therapy available decline standard therapy . Performance Status 0 1 Adequate bone marrow , kidney liver function Brain metastases require steroid Major surgery , radiation therapy , systemic anticancer therapy within 4 week study treatment start ( 6 week mitomycin C nitrosoureas ) Active clinically significant bacterial , fungal , viral infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Immunotherapy</keyword>
	<keyword>PF-04518600</keyword>
	<keyword>PF-05082566</keyword>
	<keyword>solid tumor</keyword>
	<keyword>tumor</keyword>
	<keyword>neoplasm metastasis</keyword>
	<keyword>Phase 1</keyword>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>HCC</keyword>
	<keyword>Liver cancer</keyword>
	<keyword>melanoma</keyword>
	<keyword>clear cell renal cell carcinoma</keyword>
	<keyword>RCC</keyword>
	<keyword>kidney cancer</keyword>
	<keyword>head neck squamous cell carcinoma</keyword>
	<keyword>HNSCC</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>cancer cervix</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>stomach cancer</keyword>
	<keyword>non small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>lung cancer</keyword>
	<keyword>urothelial bladder carcinoma</keyword>
	<keyword>bladder cancer</keyword>
	<keyword>OX40</keyword>
	<keyword>4-1BB</keyword>
</DOC>